Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

XRN vs CTRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTRE Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

CTRE Overall Winner 6-Pillar Tally: XRN 0 – 6 CTRE Matrix Metrics: XRN 0 – 10 CTRE

As of Nov 17, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over XRN (XRN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). XRN carries a Unified Composite Score of 45.3/100 (HOLD) at $25.79 (N/M Forward P/E, N/A operating margin), whereas CTRE carries 56.4/100 (HOLD) at $37.23 (19.7x Forward P/E, 66.2% operating margin).

  • Technical & Structure Timing Caution: XRN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.5); meanwhile CTRE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About XRN vs CTRE
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.50β · 47% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 28
RSI-14: 28.5 · SMA20: $28.74 · SMA50: $32.14
CTRE NYSE Head-to-Head Winner
CareTrust REIT, Inc
Real Estate Investment Trusts
$37.23
-0.43% 1D
Market Cap $9.8B
TTM Revenue $615M
Forward P/E 19.7x
Beta / 30D Vol 0.16β · 28% Vol
Unified Composite Score
56.4 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.3%) with fading momentum, RSI 49
RSI-14: 48.9 · SMA20: $37.17 · SMA50: $37.12

6-Pillar Scorecard Institutional Category Breakdown (XRN 0 – 6 CTRE)

Columns: Metric · XRN · CTRE
1. Valuation Multiples CTRE
Forward P/E N/M 19.7x
Trailing P/E N/M 23.9x
PEG Ratio N/M 1.26x
EV / Revenue N/M 18.5x
2. Growth & Scale CTRE
Revenue Growth (YoY) N/A +33.2%
Earnings Growth (YoY) N/A -0.8%
TTM Revenue (USD) N/A $615M
Market Cap N/A $9.8B
3. Profitability & Quality CTRE
Gross Margin N/A 95.7%
Operating Margin N/A 66.2%
Net Profit Margin N/A 59.2%
Return on Equity (ROE) N/A 7.7%
4. Balance Sheet & Cash Flow CTRE
Cash Generation (TTM) N/A $485M
Cash Flow Margin N/A 78.8%
Net Cash / Leverage N/A ROE $1.59B Net Debt (0.39x D/E)
Dividend Yield None (0.00%) 3.94%
5. Options & Positioning CTRE
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 25.1% (11th %ile)
Put/Call OI Skew N/A 6.00x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Distribution
6. R&D & Supply-Chain Moat CTRE
OpEx & R&D Intensity N/A 29.5% of Rev ($182M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Institutional Equity Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: XRN (0) vs CTRE (10)
Institutional Metric XRN CTRE Criterion Row Edge
Market Capitalization
Scale
N/A $9.8B Larger Scale CTRE
Trailing P/E Ratio
Valuation
N/M 23.9x Lower Multiple CTRE
Forward P/E Ratio
Valuation
N/M 19.7x Lower Multiple CTRE
Revenue Growth (YoY)
Growth
N/A +33.2% Higher Growth CTRE
Operating Margin (TTM)
Profitability
N/A 66.2% Higher Margin CTRE
Net Profit Margin
Profitability
N/A 59.2% Higher Margin CTRE
Return on Equity (ROE)
Capital Efficiency
N/A 7.7% Higher ROE CTRE
52-Week Range Position
Momentum
1% ($26–$39) 28% ($35–$44) Stronger Trend CTRE
Beta / 30D Volatility
Risk Regime
0.50β · 47% Vol 0.16β · 28% Vol Lower Realized Risk CTRE
Unified Institutional Score
Composite Signal
45.3 / 100 (HOLD) 56.4 / 100 (HOLD) Higher Composite CTRE
Trailing 12M Revenue (USD)
Operating Scale
N/A $615M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 95.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.26x PEG · 18.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $485M ($1.59B Net Debt (0.39x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CTRE +16.9 pp
XRN: -13.02% · CTRE: +3.88%
3M Horizon CTRE +23.55 pp
XRN: -30.05% · CTRE: -6.5%
6M Horizon CTRE +15.15 pp
XRN: -24.9% · CTRE: -9.75%
1Y Horizon CTRE +20.09 pp
XRN: -28.16% · CTRE: -8.07%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XRN vs CTRE. Trailing 12-month operating profitability (XRN N/A vs CTRE 66.2%) and valuation multiples (XRN N/M vs CTRE 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.

XRN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CTRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$615M
Gross Margin95.7%
Op. Margin66.2%
ROE / Fwd P/E7.7% · 19.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
XRN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XRN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CTRE CONSOLIDATION
84d in phase · OBV DISTRIBUTION
Current IV 25.1%
IV Percentile 11th %ile
Put/Call OI Skew 6.00x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact CTRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $37.39 · IV 27.6%

CTRE Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($3,739)

Compare $3,739 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 27.6% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $37.5 / $40 Bull Call Spread

Buy 1x $37.5C · Sell 1x $40C · 32d

Net Entry $88 Debit
T+5d @ +5% Move +$62 (+70%)
Max Risk / Buffer $88 Capped
5d Edge & Liquidity 1.0x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $35 / $32.5 Bull Put Spread

Sell 3x $35P · Buy 3x $32.5P · 60d

Net Entry $60 Credit
Max Credit / Yield +$60 (+8.7% RoM)
Max Risk / Buffer -6.9% Cushion ($690 Mgn)
5d Edge & Liquidity 77% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
XRN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CTRE Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $9.8B market capitalization and 66.2% operating margin.
OpEx & R&D Reinvestment 29.5% of Rev ($182M)
90D Engineering Disclosures 0 Published

Investor FAQ XRN vs CTRE Key Questions & Quantitative Answers

As of Nov 17, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over XRN (XRN) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). XRN carries a Unified Composite Score of 45.3/100 (HOLD) at $25.79 (N/M Forward P/E, N/A operating margin), whereas CTRE carries 56.4/100 (HOLD) at $37.23 (19.7x Forward P/E, 66.2% operating margin). Technical & Structure Timing Caution: XRN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.5); meanwhile CTRE is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CTRE leads the Growth & Scale pillar: XRN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CTRE at +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin). On trailing 12-month operating scale, XRN generates N/A in USD-normalized revenue versus $615M for CTRE. In operating R&D and SG&A reinvestment, XRN deploys N/A (0 90-day corporate R&D disclosures) versus 29.5% of Rev ($182M) (0 disclosures) for CTRE.

CTRE screens cheaper on headline valuation multiples. XRN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CTRE trades at 19.7x Forward P/E, 23.9x Trailing P/E, 1.26x PEG, and 18.5x EV/Revenue (78.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XRN (N/A ROE) versus CTRE (7.7% ROE) capital efficiency.

In options market volatility and institutional positioning, XRN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 47% Vol realized risk). By comparison, CTRE carries 25.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 6.00x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.16β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.